Hussman Strategic Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.08M Buy
63,000
+52,500
+500% +$898K 0.25% 138
2025
Q1
$670K Buy
+10,500
New +$670K 0.16% 184